Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Akari Therapeutics ( (AKTX) ) just unveiled an update.
Akari Therapeutics announced a leadership change, with the termination of Wendy DiCicco’s role as Interim Chief Financial Officer. Samir Patel, the Interim CEO, has been appointed as Interim Principal Financial Officer and Principal Accounting Officer while the search for a permanent CFO is underway.
More about Akari Therapeutics
YTD Price Performance: -68.59%
Average Trading Volume: 37,647
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.9M
See more data about AKTX stock on TipRanks’ Stock Analysis page.
